Enhanced cytotoxic activity of Moringa oleifera-loaded pharmacosomes against neuroblastoma.

This laboratory study investigated whether packaging Moringa oleifera extract into special nanocarriers called pharmacosomes could improve its effectiveness against neuroblastoma, a type of childhood cancer. Researchers created tiny spherical particles (41-190 nanometers) using phospholipids, lecithin, and chitosan to carry the moringa extract. They tested these particles on neuroblastoma cancer cells in laboratory dishes. The results showed that the moringa-loaded nanoparticles were much more effective at killing cancer cells than regular moringa extract alone - about 10 times more powerful. The nanoparticles disrupted the cancer cells' ability to divide and grow normally, causing them to get stuck in certain phases of cell division. The researchers identified several beneficial compounds in the moringa extract through chemical analysis, including polyphenolic acids, flavonoids, and other bioactive substances. Importantly, the empty nanoparticles without moringa showed minimal toxicity to normal human cells, suggesting the carrier system is safe. This research suggests that packaging moringa extract in specialized nanocarriers could potentially make it a more effective treatment for neuroblastoma, though much more research including animal studies and clinical trials would be needed before any medical applications.